Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 |
| Gross Profit | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 |
| Operating Expenses | 57,792 | 51,133 | 47,587 | 47,631 | 43,858 |
| Operating Income | -50,355 | -46,421 | -42,041 | -19,310 | 126,780 |
| Other Income | 6,637 | 7,082 | 7,442 | 7,655 | 6,884 |
| Pre-tax Income | -43,718 | -39,339 | -34,599 | -11,655 | 133,664 |
| Income Tax | 666 | N/A | 172 | N/A | 1,990 |
| Net Income Continuous | -44,384 | -39,339 | -34,771 | -11,655 | 131,674 |
| Net Income | $-44,384 | $-39,339 | $-34,771 | $-11,655 | $131,674 |
| EPS Basic Total Ops | -0.69 | -0.62 | -0.55 | -0.19 | 2.10 |
| EPS Basic Continuous Ops | -0.70 | -0.62 | -0.55 | -0.19 | 2.10 |
| EPS Diluted Total Ops | -0.69 | -0.62 | -0.55 | -0.19 | 2.01 |
| EPS Diluted Continuous Ops | -0.70 | -0.62 | -0.55 | -0.19 | 2.01 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.62 | -0.55 | -0.19 | 1.98 |
| EBITDA(a) | $-50,970 | $-46,501 | $-44,220 | $-20,791 | $124,556 |